Thilo Schroeder

Synnovation Therapeutics is a precision oncology company that develops therapeutics that aims to help people with cancer.

Raised $138,999,773.00 from Cormorant Asset Management, Lilly Asia Ventures, Third Rock Ventures, Sirona Capital and Nextech Invest.

Alterome Therapeutics is a biopharmaceutical company developing alteration-specific targeted therapies.

Raised $231,000,000.00 from Driehaus Capital Management, Goldman Sachs, Boxer Capital, Colt Ventures, Digitalis Ventures, Invus, Vida Ventures, Blue Owl, Nextech Invest and Canaan Partners.

Atavistik Bio is a biotechnology company that focuses on the discovery and development of novel therapies for metabolic diseases and cancer.

Raised $100,000,000.00 from Lux Capital, Nextech Invest and The Column Group.

Circle Pharma is a biotechnology company creating bioavailable macrocyclic peptide therapeutics that target protein-protein interactions.

Raised $207,500,000.00 from Pandect Bioventures, Nextech Invest, The Column Group, Eli Lilly and Euclidean Capital.

Revolution Medicines is an innovative and dynamic organization of expert biologists, chemists, pharmacologists, clinical scientists.

Raised $2,004,400,000.00 from Nextech Invest, Boxer Capital, Schroder Adveq, Cormorant Capital, Casdin Capital, Vivo Capital, Biotechnology Value Fund, Deerfield Capital Management, Third Rock Ventures and Fidelity.

Mariana Oncology is a biotechnology research industry.

Raised $250,000,000.00 from RA Capital Management, Nextech Invest, Surveyor Capital, Atlas Ventures, Forbion Capital Partners, Deep Track Capital, Eli Lilly and Access Biotechnology.

CARGO Therapeutics develops an adoptive cell therapy to benefit patients from potentially curative treatment options.

Raised $310,000,000.00 from Woodline Partners, Ally Bridge Group, Saturn V Capital, Novo Holdings, Perceptive Advisors, T. Rowe Price, Wellington Management, Third Rock Ventures, Opaleye Management and Samsara BioCapital.